Rifaximin for the treatment of diarrhea-predominant irritable bowel syndrome.
about
Effect of TongXie-YaoFang on Cl(-) and HCO3 (-) Transport in Diarrhea-Predominant Irritable Bowel Syndrome Rats.Eluxadoline for the treatment of diarrhoea-predominant irritable bowel syndrome.Emergence of rifampin-resistant staphylococci after rifaximin administration in cirrhotic patients.The Gut-Brain Axis and the Microbiome: Clues to Pathophysiology and Opportunities for Novel Management Strategies in Irritable Bowel Syndrome (IBS).Structural Modulation of Gut Microbiota during Alleviation of Suckling Piglets Diarrhoea with Herbal Formula.
P2860
Rifaximin for the treatment of diarrhea-predominant irritable bowel syndrome.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Rifaximin for the treatment of diarrhea-predominant irritable bowel syndrome.
@en
Rifaximin for the treatment of diarrhea-predominant irritable bowel syndrome.
@en-gb
type
label
Rifaximin for the treatment of diarrhea-predominant irritable bowel syndrome.
@en
Rifaximin for the treatment of diarrhea-predominant irritable bowel syndrome.
@en-gb
prefLabel
Rifaximin for the treatment of diarrhea-predominant irritable bowel syndrome.
@en
Rifaximin for the treatment of diarrhea-predominant irritable bowel syndrome.
@en-gb
P2860
P1476
Rifaximin for the treatment of diarrhea-predominant irritable bowel syndrome.
@en
P2093
John S Kane
P2860
P304
P356
10.1586/17474124.2016.1140571
P577
2016-01-12T00:00:00Z